SION Sionna Corp: Narxning prognoz qilingan daromadga nisbati

Sionna Therapeutics (SION) kompaniyasining rasmiy ramzlari

Sionna Therapeutics Inc (SION) jamoasi ventura investitsiyalari va sherikliklardan foydalangan holda, genetik patologiyalarni davolashda chuqur ilmiy ekspertizaga ega. Kutilayotgan sotuvlar nisbati (price-to-sales ratio) biznesning baholanishi va kelajakdagi marjlar o'rtasidagi muvofiqlikni namoyish etadi, bunda ko'rsatkichi ushbu darajani belgilaydi. Biroq, kompaniyaning rivojlanishi FDA ning qat'iy nazorati, moliyalashtirish yetishmasligi xavfi va klinik sinovlar natijalariga bog'liqlik bilan cheklangan.

Sionna Therapeutics - SION Forvard P/S multiplikatori (davr: 04.07.2022 - 17.11.2026)

SION (Sionna Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning fundamental tahlili:Sionna Therapeutics (SION)
sionnatx.com tovar namunasi

Forward P/S ko'rsatkichi joriy bozor kapitalizatsiyasini kutilayotgan daromad hajmlari bilan bog'lagan holda, kengayish potentsialining bozor premiumini o'lchaydi. Forward P/S koeffitsiyenti orqali investor aktivning shishirilgan baholanishi bozor ulushini egallash sur'atiga nisbatan asoslangan yoki yo'qligini baholaydi. Forward P/S koeffitsiyentidagi tendentsiya spekulyativ cho'qqilarni fundamental o'sishdan ajratish imkonini beradi. Sionna Therapeutics Inc (SION) uchun bunday baholash juda muhimdir, chunki terapiyaning muvaffaqiyati bevosita biomateriallar uchun kriogen logistikaning murakkabligi va ishonchliligiga bog'liq.

Raqobatdosh kompaniyalar

Forvard P/S multiplikatori TEM (Tempus Labs)|Qiagen N.V. - Narxning prognoz qilingan daromadga nisbati|IONS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati repligen.com|RNA: Forvard P/S multiplikatori|CRISPR Therapeutics Inc (CRSP) - Forvard P/S multiplikatori|WGS (GeneDx Holdings) - Forvard P/S multiplikatori|RARE: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori BEAM (Beam Therapeutics Corp)|SRPT: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori TWST (Twist Bioscience Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati 10x Genomics Corp (TXG)|intelliatx.com - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Stoke STOK|biolifesolutions.com (BLFS) - Narxning prognoz qilingan daromadga nisbati|WVE - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori MAZE|Forvard narx/daromad multiplikatori Prime Medicine Corp (PRME)|Forvard P/S multiplikatori TSHA|Forvard P/S multiplikatori uniQure N.V. (QURE)|Narxning prognoz qilingan daromadga nisbati MeiraGTx Holdings plc MGTX|RGNX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Solid Biosciences Inc - Forvard P/S multiplikatori|OCGN - Forvard P/S multiplikatori|PACB: Forvard P/S multiplikatori|BNTC - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Design Therapeutics, Inc.|RCKT: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori FDMT (4D Molecular Therapeutics, Inc.)|Lexeo Therapeutics, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Korro Bio, Inc. KRRO|EDIT: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|SLN - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati ProQR Therapeutics (PRQR)|CDXS (Codexis Bio) - Forvard narx/daromad multiplikatori|Sangamo Therapeutics Inc. (SGMO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Nautilus Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Metagenomi Therapeutics MGX|Narxning prognoz qilingan daromadga nisbati Precision BioSciences (DTIL)|GBIO - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori BOLD (Boundless Bio, Inc)|XCUR - Forvard narx/daromad multiplikatori|IMNN - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Phio Pharmaceuticals Corp|MBIO: Forvard P/S multiplikatori|TransCode (RNAZ) - Forvard P/S multiplikatori|BNGO (Bionano) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Applied DNA Sciences, Inc. APDN|Forvard P/S multiplikatori BLUE|ImmunoPrecise Antibodies Ltd - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Omega Therapeutics OMGA|OMIC: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|RGLS: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx SYRS (Syros Pharmaceuticals, Inc.)|Telesis Bio, Inc. (TBIO) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati TCON (TRACON)|Narxning prognoz qilingan daromadga nisbati Unity Biotechnology, Inc.